| Posts by LJM |
| Message | Subject | Recs | Posted |
Awesome re: Coursera course on SDN. Thanks!!!  | EZchip Semiconductor | 1 | May 1 |
| sdncentral.com Another article I'm parking for future reference re: S | EZchip Semiconductor | 1 | April 26 |
| woodsidecap.com Interesting article. Parking it here because of the rece | EZchip Semiconductor | 3 | April 26 |
| Bulba = Sorry I missed deadline on EST. Just use next close. No worries. INCY | 2013 Biotech Charity Contest | | 12/31/2012 |
| Congratulations GeneGuru!!! It was an exciting finish... ;-) 150.00 Donation | 2012 Biotech Charity Contest | | 12/31/2012 |
| 2012 stock picks: MNTA 20% MITI 10% ARIA 10% TSRX 10% DEPO | 2012 Biotech Charity Contest | | 1/4/2012 |
| Congrats McBio! $100.00 paid to United Teen Equality Center utec-lowell.org | 2011 Biotech Charity Contest | | 12/27/2011 |
IN lisa  | 2011 Biotech Charity Contest | | 12/19/2011 |
Thank you for pointing me to that presentation.  | Acme Packet (APKT) | | 11/2/2011 |
| Interesting move in APKT today? While the NAZ bleeds, APKT is up over 8 percent | Acme Packet (APKT) | | 11/1/2011 |
| Thanks for your link.... Are the Green boxes on your chart all primary waves? | E-Wave and TA Workspace | | 2/14/2011 |
| Hi Henry, I just want to confirm I've got this LT count by degrees straight | E-Wave and TA Workspace | | 2/14/2011 |
| Looking at slide 19 again, I think it could be interpreted that a deficiency let | Momenta Pharmaceuticals Inc. | | 1/25/2011 |
| Good find on those slides. I would agree with you after looking at the slides. | Momenta Pharmaceuticals Inc. | | 1/25/2011 |
FDA response to TEVA ANDA. finance.yahoo.com  | Momenta Pharmaceuticals Inc. | | 1/25/2011 |
| Interesting charts... very helpful. I only recently located this board, so I ha | E-Wave and TA Workspace | | 12/30/2010 |
| Thanks Henry. How about that Red c you have at the March low on LT Chart? Is t | E-Wave and TA Workspace | | 12/29/2010 |
| Happy Holiday's Bulbaman. ;-) Glad to donate to your charity for all your | 2010 Biotech Charity Contest | | 12/29/2010 |
| MNTA 20 INCY 15 EXEL 10 ARRY 10 ARQL 10 MITI 15 A | 2011 Biotech Charity Contest | | 12/29/2010 |
| Nice "repeat" Jim. I'm not surprised. ;-) Donation made today | 2010 Biotech Charity Contest | | 12/29/2010 |
| Henry, Your white boxed wave 1 and 2 from LT chart - are they Primary Degree wa | E-Wave and TA Workspace | | 12/29/2010 |
| Incyte Announces Positive Top-Line Results from COMFORT-I Pivotal Phase III Tria | Incyte Pharmaceuticals (INCY) | | 12/20/2010 |
| Wilder, McCarthy is one of my favs. Thanks for that link. Hope you are doing | Biotech Valuation | | 11/16/2010 |
| FWIW - I don't own this one anymore. However, those that do might find this | Exelixis, Inc. (EXEL) | | 11/11/2010 |
| Hi Rick, I'm reading Franzen's new book "Freedom" right now. | Biotech Stock Picking for Charity - 2007 | | 9/27/2010 |
| Nigel, You made my day and it is about time re: CRXL. JNJ needs to sweeten th | biotech fireworks | | 9/17/2010 |
| Hey you? How is everything? I've read that book. It was a satisfying read | Biotech Stock Picking for Charity - 2007 | | 3/30/2010 |
| Awesome performance. Donation complete. lisa * Nigel - if you catch him, I wi | 2009 Biotech Charity Contest | | 12/6/2009 |
| Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozyg | Isis Pharmaceuticals (ISIP) | | 5/20/2009 |
| Isis and Alnylam Form New Collaboration to Develop Single-Stranded RNAi Technolo | Isis Pharmaceuticals (ISIP) | | 4/29/2009 |
| Aeras and Crucell Announce Start of TB Infant Study in South Africa Apr 28, 200 | Crucell N.V. (CRXL) | | 4/28/2009 |
| Genentech exec named Geron oncology CMO Silicon Valley / San Jose Business Journ | Geron Corp. | | 4/27/2009 |
| Supreme Court Denies Sanofi Appeal In Lovenox Patent Case>SNY Apr 27, 2009 | Momenta Pharmaceuticals Inc. | | 4/27/2009 |
| Xenoport and GlaxoSmithKline announce results results from a Phase II clinical | Xenoport | | 4/27/2009 |
| Array BioPharma's ARRY-543 Shows Potential Clinical Benefit in Cancer Patien | Array Pharmaceuticals ARRY | | 4/21/2009 |
| Array BioPharma's ARRY-520 Demonstrates Significant Activity in Hematologic | Array Pharmaceuticals ARRY | | 4/21/2009 |
| SAN DIEGO, PHILADELPHIA and REHOVOT, Israel, April 13, 2009 /PRNewswire via COMT | Rosetta Genomics (ROSG) - microRNA | | 4/13/2009 |
ROSG - up about 21 percent on Prometheus collaboration.  | biotech fireworks | | 4/13/2009 |
| Array BioPharma Announces Eighteen Abstracts Selected for Presentation at 2009 A | Array Pharmaceuticals ARRY | | 4/6/2009 |
| OT > Interesting article in Financial Times. Seems like a rather obvious so | Biotech Valuation | | 4/5/2009 |
| Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on | MEDX ... anybody following? | | 3/31/2009 |
| Study Published by Rosetta Genomics and Collaborators in the Journal of Clinical | Rosetta Genomics (ROSG) - microRNA | | 3/9/2009 |
| news.yahoo.com WASHINGTON – President Barack Obama is expected to sign an | Stem Cell Research | | 3/6/2009 |
| I actually spoke to the CMO and he parsed through the pr and the numbers with me | Repros Therapeutics (RPRX) | | 1/13/2009 |
| Somebody must have made a typo. ;-) Medarex expects a cash burn rate per month | MEDX ... anybody following? | | 1/13/2009 |
| Repros Therapeutics Inc. Announces That Proellex Significantly Reduced Pain in a | Repros Therapeutics (RPRX) | | 1/12/2009 |
| seekingalpha.com Five Reason Repros Therapeutics Is Hitting 52-Week High | Repros Therapeutics (RPRX) | | 1/9/2009 |
| Bulba - thanks for your reply. I am removing CRXL and just adjusting the percen | 2009 Biotech Charity Contest | | 1/8/2009 |
| Nigel I'm thinking the upside on CRXL will be mostly over by 1/9 and the co | 2009 Biotech Charity Contest | | 1/7/2009 |
| Bulba - Yes - what do we do about CRXL? I have it as a charity pick. Should I | 2009 Biotech Charity Contest | | 1/7/2009 |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.